Results 271 to 280 of about 450,538 (349)

First-Trimester Antibiotic Use for Urinary Tract Infection and Risk of Congenital Malformations.

JAMA Netw Open
Osmundson SS, Nickel KB, Shortreed SM, Dublin S, Stwalley D, Durkin MJ, Wartko PD, Sahrmann JM, Colvin R, Butler AM.   +9 more
europepmc   +1 more source

Rare Urinary Tract Infection by Rodentibacter pneumotropicus (formerly, Pasteurella pneumotropica) in an Immunocompetent Patient. [PDF]

Am J Case Rep
Soto-Vega E, Bello-Rossette E, Cabrera-Martínez MDC, Arroyo Kuribreña JC.   +3 more
europepmc   +1 more source

Decline in gut motility of cerebral palsy patients after a triggering event: A discussion on invasive versus conservative management

JPGN Reports, EarlyView.
Abstract Objectives Patients with cerebral palsy (CP) often have gastrointestinal dysmotility. An inciting event, such as infection, may lead to progressive decline in bowel motility and episodes of acute pediatric intestinal pseudo‐obstruction (PIPO).
Zoe Saenz, Elizabeth Reynolds, Jamie E. Anderson, Payam Saadai, Maheen Hassan   +4 more
wiley   +1 more source

A case of autoimmune hepatitis in a patient with inflammatory bowel disease and significant lymphadenopathy in the porta hepatis

JPGN Reports, EarlyView.
Abstract The diagnosis of autoimmune hepatitis (AIH) is supported by the presence of elevated transaminases, hypergammaglobulinemia, liver biopsy consistent with AIH, and the presence of AIH autoantibodies. In this case presentation, we highlight the challenges associated with diagnosing AIH in a patient with inflammatory bowel disease (IBD) who ...
Benjamin J. Malamet, Shannon Joerger, Karen Caudill, Mai He, Juan Reyes Genere, Janis Stoll   +5 more
wiley   +1 more source

Efficacy of D-mannose as prophylaxis of recurrent urinary tract infection: a systematic review and meta-analysis of randomized controlled trials. [PDF]

J Bras Nefrol
Vargas CEF, Mutarelli A, Menegardo LG, Silva AKBD, Vieira PRB, Luz JD, Felix N, Pinto LCS.   +7 more
europepmc   +1 more source

The Role of Vitamins in Pediatric Urinary Tract Infection: Mechanisms and Integrative Strategies. [PDF]

Biomolecules
Wróblewska J, Złocińska H, Wróblewski M, Nuszkiewicz J, Woźniak A.   +4 more
europepmc   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg   +11 more
wiley   +1 more source